Resize Text Search
  • Call 888.905.6071
  • Doctors offering 24/7 online appointment scheduling
  • Request an appointment
  • MyChart current patient scheduling
General Inquiries

Weight-Loss App Shown to Aid Endometrial and Breast Cancer Patients

Date: 03.24.2014
Contact: Jim Gosky Phone: (234) 312-5052

TAMPA, FL March 23, 2014 – Overweight endometrial and breast cancer survivors – at higher risk for premature death – had moderate success in lowering body mass index (BMI) and waist circumference (WC) using the web and smart phone/tablet-based weight loss application, “Lose It!”

A study conducted by Summa Health System researchers in Akron, Ohio, provided 50 early-stage overweight women cancer survivor access to the Lose It! app and instructed them to log daily food intake and their voluntary exercise for one month. BMI and WC were assessed at the baseline and at the end of the test period for each of the 50 women. At the end of the 30-day test period, both BMI and WC were reduced by three to four percent.

“What our research found parallels the recent SUCCEED (Survivors of Uterine Cancer Empowered by Exercise and healthy Diet) trial,” said lead author Michele McCarroll, Ph.D., Director of Women's Health Research at Summa Health System’s Center for Women's Health Research, and an Assistant Professor for the Department of Obstetrics and Gynecology at Northeast Ohio Medical University. “We were very encouraged by the findings which validate that a lifestyle intervention using an application like Lose It! is a feasible option for short-term weight loss. Further, through this approach the patient does not face some of the cost and health care provider access issues normally associated with more face-to-face traditional weight loss programs.”

Dr. McCarroll will speak on this research during a 1:45-3 p.m. focused oral plenary session on March 23 at the Society of Gynecologic Oncology’s 45th Annual Meeting on Women’s Cancer in Tampa from March 22-25. Dr. McCarroll’s research colleagues on this study were: Shannon Armbruster, M.D.; Rachael J. Pohle-Krauza, Ph.D., R.D.N., L.D; Amy M Lyzen, B.S.; Nathan Fagan, M.D.; Sarah Min, B.S.; G. Dante Roulette, M.D.; Stephen J. Andrews, M.D.; and Vivian E. von Gruenigen, M.D.

About Summa Health System
Summa Health System is one of the largest integrated healthcare delivery systems in Ohio. Encompassing a network of hospitals, community health centers, a health plan, a physician-hospital organization, a multi-specialty physician organization, research and multiple foundations, Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery. Summa's clinical services are consistently recognized by the American Nurses Credentialing Center (Magnet® status), U.S. News and World Report, Thomson Reuters and The Leapfrog Group. Summa also is a founding partner of the Austen BioInnovation Institute in Akron. For more information, visit or find us on Facebook at and Twitter at